11-year-old Jacob Peckham from Detroit trials gene-editing treatment for Retinitis Pigmentosa, a genetic eye condition.

11-year-old Jacob Peckham from Detroit is among the first people to try a new experimental gene-editing treatment for Retinitis Pigmentosa, a genetic eye condition affecting his vision. The treatment, if successful, could potentially help others with the same condition. Jacob admits feeling a bit scared, but he's excited about the possibility of helping others.